S
Steen Z. Abildstrom
Researcher at University of Southern Denmark
Publications - 101
Citations - 8651
Steen Z. Abildstrom is an academic researcher from University of Southern Denmark. The author has contributed to research in topics: Myocardial infarction & Hazard ratio. The author has an hindex of 38, co-authored 99 publications receiving 7964 citations. Previous affiliations of Steen Z. Abildstrom include University of Copenhagen & Bispebjerg Hospital.
Papers
More filters
Journal ArticleDOI
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.
Morten Lock Hansen,Rikke Sørensen,Mette T. Clausen,Marie Louise Fog-Petersen,Jakob Raunsø,Niels Gadsbøll,Gunnar Gislason,Fredrik Folke,Søren Andersen,Tina Ken Schramm,Steen Z. Abildstrom,Henrik E. Poulsen,Lars Køber,Christian Torp-Pedersen +13 more
TL;DR: In patients with AF, all combinations of warfarin, aspirin, and clopidogrel are associated with increased risk of nonfatal and fatal bleeding.
Journal ArticleDOI
Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events
Lasse Jespersen,Anders Hvelplund,Steen Z. Abildstrom,Frants Pedersen,Søren Galatius,Jan Madsen,Erik Jørgensen,Henning Kelbæk,Eva Prescott +8 more
TL;DR: Patients with stable angina and normal coronary arteries or diffuse non-obstructive CAD have elevated risks of MACE and all-cause mortality compared with a reference population without ischaemic heart disease.
Journal ArticleDOI
Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data
Rikke Sørensen,Morten Lock Hansen,Steen Z. Abildstrom,Steen Z. Abildstrom,Anders Hvelplund,Charlotte Andersson,Casper H. Jørgensen,Jan Kyst Madsen,Peter Riis Hansen,Lars Køber,Christian Torp-Pedersen,Gunnar Gislason +11 more
TL;DR: In patients with myocardial infarction, risk of hospital admission for bleeding increased with the number of antithrombotic drugs used, and treatment with triple therapy or dual therapy with clopidogrel plus vitamin K antagonist should be prescribed only after thorough individual risk assessment.
Journal ArticleDOI
Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People
Tina Ken Schramm,Gunnar Gislason,Lars Køber,Søren K. Rasmussen,Jeppe Nørgaard Rasmussen,Steen Z. Abildstrom,Morten Lock Hansen,Fredrik Folke,Pernille Buch,Mette Madsen,Allan Vaag,Christian Torp-Pedersen +11 more
TL;DR: Patients requiring glucose-lowering therapy who were ≥30 years of age exhibited a cardiovascular risk comparable to nondiabetics with a prior myocardial infarction, regardless of sex and diabetes type, and requirement for glucose- Lowering therapy should prompt intensive prophylactic treatment for cardiovascular diseases.
Journal ArticleDOI
The validity of the diagnosis of acute myocardial infarction in routine statistics: A comparison of mortality and hospital discharge data with the Danish MONICA registry
TL;DR: The combination of the national registries was found to be a valid and powerful tool for monitoring the population incidence of MI.